Advances in the management of pancreatic ductal adenocarcinoma
Grainne M. O’Kane, Farah Ladak, Steven Gallinger
Abstract
KEY POINTS The incidence of pancreatic ductal adenocarcinoma (PDAC) is rising and PDAC is projected to become the third leading cause of cancer death in Canada.[1][1] Although risk factors for PDAC are known, the reason for its rising incidence is not. Overall survival for this disease at 5 years
Topics & Concepts
Pancreatic ductal adenocarcinomaIncidence (geometry)Pancreatic cancerAdenocarcinomaMedicineInternal medicineDiseaseOncologyCancerOpticsPhysicsPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsCholangiocarcinoma and Gallbladder Cancer Studies